FORMYCON AG (FYB.DE) Stock Price, Quote, News and Overview
FRA:FYB - Deutsche Boerse Ag - DE000A1EWVY8 - Common Stock - Currency: EUR
FYB.DE Quote, Performance and Key Statistics
FRA:FYB (3/26/2025, 1:26:40 PM)
26.2
0 (0%)
The current stock price of FYB.DE is 26.2 EUR. In the past month the price decreased by -3.5%. In the past year, price decreased by -43.47%.
FYB.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1ABBV.MI | ABBVIE INC | 20.71 | 341.81B | ||
| 4AB.DE | ABBVIE INC | 20.04 | 330.79B | ||
| AMG.DE | AMGEN INC | 15.58 | 153.24B | ||
| GIS.DE | GILEAD SCIENCES INC | 23.27 | 123.43B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 1736.67 | 120.41B | ||
| ARGX.BR | ARGENX SE | 343.13 | 33.36B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 21.56B | ||
| IDP.DE | BIOGEN INC | 8.55 | 19.04B | ||
| 1MRNA.MI | MODERNA INC | N/A | 12.15B | ||
| 0QF.DE | MODERNA INC | N/A | 12.09B | ||
| BIO.DE | BIOTEST AG | 23.86 | 1.61B | ||
| GLPG.AS | GALAPAGOS NV | 21.29 | 1.57B |
Related stock screener links
About FYB.DE
Company Profile
Formycon AG engages in the manufacture of biosimilar drugs and formulations. The company is headquartered in Martinsried, Bayern and currently employs 239 full-time employees. The company went IPO on 2010-12-20. Its business activities are focused on the development and marketing of biopharmaceuticals that are similar to existing drugs, for which the patent protection is expiring. The firm focuses on treatments in the area of ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval. Its biosimilar product pipeline consists of four candidates in pre-clinical and clinical testing phases, including FYB201, a biosimilar candidate for Lucentis; FYB202, a biosimilar candidate for Stelara; FYB203, a biosimilar candidate for Eylea, and FYB205.
Company Info
FORMYCON AG
Fraunhoferstrasse 15
Martinsried BAYERN DE
Employees: 239
Company Website: https://www.formycon.com/
Investor Relations: http://www.formycon.com/investors/financial-reports/
Phone: 4989864667100
FORMYCON AG / FYB.DE FAQ
What is the stock price of FORMYCON AG today?
The current stock price of FYB.DE is 26.2 EUR.
What is the ticker symbol for FORMYCON AG stock?
The exchange symbol of FORMYCON AG is FYB and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is FYB.DE stock listed?
FYB.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for FORMYCON AG stock?
15 analysts have analysed FYB.DE and the average price target is 67.69 EUR. This implies a price increase of 158.36% is expected in the next year compared to the current price of 26.2. Check the FORMYCON AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is FORMYCON AG worth?
FORMYCON AG (FYB.DE) has a market capitalization of 462.69M EUR. This makes FYB.DE a Small Cap stock.
How many employees does FORMYCON AG have?
FORMYCON AG (FYB.DE) currently has 239 employees.
What are the support and resistance levels for FORMYCON AG (FYB.DE) stock?
FORMYCON AG (FYB.DE) has a resistance level at 27.6. Check the full technical report for a detailed analysis of FYB.DE support and resistance levels.
Is FORMYCON AG (FYB.DE) expected to grow?
The Revenue of FORMYCON AG (FYB.DE) is expected to decline by -23.89% in the next year. Check the estimates tab for more information on the FYB.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy FORMYCON AG (FYB.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FYB.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FYB.DE, evaluating the profitability, health, valuation and growth aspects
- FORMYCON AG (FYB.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- FORMYCON AG (FYB.DE) Sales and EPS estimates to see what analysts future expectations are.
- FORMYCON AG (FYB.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- FORMYCON AG (FYB.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- FORMYCON AG (FYB.DE) Stock Chart to make your own analysis
- FORMYCON AG (FYB.DE) Latest news and press-releases to stay up to date.
Does FORMYCON AG (FYB.DE) stock pay dividends?
FYB.DE does not pay a dividend.
When does FORMYCON AG (FYB.DE) report earnings?
FORMYCON AG (FYB.DE) will report earnings on 2025-03-27, after the market close.
What is the Price/Earnings (PE) ratio of FORMYCON AG (FYB.DE)?
The PE ratio for FORMYCON AG (FYB.DE) is 6.55. This is based on the reported non-GAAP earnings per share of 4 and the current share price of 26.2 EUR. Check the full fundamental report for a full analysis of the valuation metrics for FYB.DE.
FYB.DE Technical Analysis
FYB.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to FYB.DE. FYB.DE has only an average score on both its financial health and profitability.
FYB.DE Financial Highlights
Over the last trailing twelve months FYB.DE reported a non-GAAP Earnings per Share(EPS) of 4. The EPS increased by 243.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 105.09% | ||
| ROA | 6.74% | ||
| ROE | 11.09% | ||
| Debt/Equity | 0.02 |
FYB.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to FYB.DE. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of -144.35% and a revenue growth -23.89% for FYB.DE